Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder

Journal of Clinical Psychiatry

Volumn 58, Issue 11, 1997, Pages 470-478

  Denicoff, Kirk D ^a   Smith Jackson, Earlian E ^a   Disney, R Elizabeth ^a   Ali, S Omar ^a   Leverich, Gabriele S ^a   Post, Robert M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; FLUOXETINE; HALOPERIDOL; LITHIUM; NORTRIPTYLINE; PERPHENAZINE; THIORIDAZINE;

ADULT; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAILY LIFE ACTIVITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030666691     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v58n1102     Document Type: Article

References (54)

1. Kraepelin E. Frequency of the individual forms: general course. In: Barclay RM, Tans J, Robertson GM, eds. Manic-Depressive Insanity and Paranoia. Edinburgh, Scotland: E & S Livingstone; 1921
2. Post RM, Rubinow DR, Ballenger JC. Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 1986;149: 191-201
3. Prien RF, Himmelhoch JM, Kupfer DJ. Treatment of mixed mania. J Affect Disord 1988;15:9-15
4. Watkins SE, Callender K, Thomas DR, et al. The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiatry 1987;150: 180-182
5. Placidi GF, Lenzi A, Lazzerini F, et al. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 1986;47:490-494
6. Lusznat RM, Murphy DP, Nunn CMH. Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988;153:198-204
7. Dunner DL, Fleiss JL, Fieve RR. Lithium carbonate prophylaxis failure. BrJ Psychiatry 1976;129:40-44
8. Page C, Benaim S, Lappin F. A long-term retrospective follow-up study of patients treated with prophylactic lithium carbonate. BrJ Psychiatry 1987; 150:175-179
9. Kishimoto A, Omura F, Inoue K, et al. A comparative study of carbamazepine and lithium for prophylaxis of bipolar affective disorder. Yonago Acta Medica 1986:29:76-90
10. Baastrup PC, Schou M. Lithium as a prophylactic agent: its effect against recurrent depression and manic-depressive psychosis. Arch Gen Psychiatry 1967;16:162-172
11. Angst J, Weis P, Grof P, et al. Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry 1970;116:604-614
12. Coppen A, Noguera R, Bailey J, et al. Prophylactic lithium in affective disorders: controlled trial. Lancet 1971;2:275-279
13. Hullin RP, McDonald R, Allsopp MME. Prophylactic lithium in recurrent affective disorders. Lancet 1972; 1:1044-1046
14. Okuma T, Kishimoto A, Inoue K, et al. Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis: a preliminary report. Folia Psychiatrica et Neurologica Japonica 1973;27: 283-297
15. Prien RF, Kielt CJ, Caffey EM Jr. Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973;29:420-425
16. Itoh K, Ishigane M. On the clinical effectiveness of lithium carbonate for manic depressive reactions: therapeutic and prophylactic effects. Shinyaku-to-Rinsho 1973:22:1001-1015
17. O'Connell RA, Mayo JA, Flatow L, et al. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991;159:123-129
18. Post RM. Alternatives to lithium for bipolar affective illness. In: Tasman A, Goldfinger SM, Kaufmann CA, eds. Review of Psychiatry, vol 9. Washington, DC: American Psychiatric Press; 1990:170-202
19. Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Communications in Psychopharmacology 1978:2:159-175
20. Post RM, Uhde TW, Ballenger JC, et al. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry 1983;140: 1602-1604
21. Okuma T, Inanaga K, Otsuki S, et al. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 1981;73:95-96
22. Coxhead N, Silverstone T, Cookson J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand 1992; 85:114-118
23. Elphick M, Lyons F, Cowen PJ. Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness. J Psychopharmacol 1988;2(1):1-4
24. Cabrera JF, Muhlbauer HD, Schley J, et al. Long-term randomized clinical trial on oxcarbazepine vs lithium in bipolar and schizoaffective disorders: preliminary results. Pharmacopsychiatry 1986;19:282-283
25. Bellaire W, Demisch K, Stoll KD. Carbamazepin vs lithium. Münchener Medizinishe Wochenschrift I990;132(suppl 1):S82-S86
26. Svestka J, Nahunek K. Carbamazepine in the prophylaxis of affective psychoses [abstract]. Psychopharmacology 1988;96(suppl):287
27. Post RM, Uhde TW. Anticonvulsives in non-epileptic psychosis. In: Trimble MR, Bolwig TG, eds. Aspects of Epilepsy and Psychiatry. Chichester, England: Wiley Press; 1986:177-212
28. Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 1993:27:138-145
29. Inoue K, Arima S, Tanaka K, et al. A lithium and carbamazepine combination in the treatment of bipolar disorder: a preliminary report. Folia Psych-iatrica et Neurologica Japonica 1981 ;35:465-475
30. Lipinski JF, Pope HG. Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients. Am J Psychiatry 1982;139:948-949
31. Keisling R. Carbamazepine and lithium carbonate in the treatment of refractory affective disorders [letter]. Arch Gen Psychiatry 1983;40:223
32. Moss GR, James CR. Carbamazepine and lithium carbonate synergism in mania. Arch Gen Psychiatry 1983;40:588-589
33. Kramlinger KG, Post RM. Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatr Scand 1989;79:378-385
34. Strömgren LS. The combination of lithium and carbamazepine in treatment and prevention of manic-depressive disorder a review and a case report. Compr Psychiatry 1990;31:261-265
35. Kishimoto A. The treatment of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:483-493
36. Denicoff KD, Blake KD, Smith-Jackson EE, et al. Morbidity in treated bipolar disorder a one year prospective study using daily life chart ratings. Depression 1994;2:95-104
37. Leverich GS, Post RM. Life charting the course of bipolar disorder. Current Review of Mood and Anxiety Disorders 1996; 1:48-61
38. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
39. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, Calif: Consulting Psychologists Press; 1970
40. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
41. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978; 133:429-435
42. Raskin A, Schulterbrandt JG, Reatig N, et al. Replication of factors of psychopathology in interview, ward behavior and self-report ratings of hospitalized depressives. J Nerv Ment Dis 1969;148:87-98
43. Prien RF, Kupfer DJ, Mansky PA, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: report of the NIMH collaborative study group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984; 41:1096-1104
44. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
45. SAS Institute Inc. SAS/STAT User's Guide, version 6.4th ed. vol 2. Cary, NC: SAS Institute; 1989:1071-1126
46. Simhandl CH, Denk E, Thau LK. The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders. J Affect Disord 1993;28:221-231
47. Crill WE. Drugs 5 years later: carbamazepine. Ann Intern Med 1973;79: 844-847
48. Kramlinger KG, Phillips KA, Post RM. Rash complicating carbamazepine treatment. J Clin Psychopharmacol 1994;14:408-413
49. Okuma T, Yamashita I, Takahashi R, et al. Clinical efficacy of carbamazepine in affective, schizoaffective, and schizophrenic disorders. Pharmacopsychiatry 1989;22:47-53
50. Post RM, Uhde TW, Ballenger JC, et al. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF: relationship to antidepressant response. Arch Gen Psychiatry 1983;40:673-676
51. Gelenberg AJ, Kane JM, Keller MB, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-1493
52. Joyce PR. Carbamazepine in rapid cycling bipolar affective disorder. Int Clin Psychopharmacol 1988;3:123-129
53. Post RM, Kramlinger KG, Altshuler LL, et al. Rapid cycling bipolar disorder: treatment of rapid cycling bipolar illness. Psychopharmacol Bull 1990;26(1):37-47
54. Di Costanzo E, Schifano F. Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiatr Scand 1991;83:456-459